2-{1-[3-(2-fluoro-pyridin-3-yl)-phenyl]-1h-benzoimidazol-5-yl}-propan-2-ol and its use for the manufacture of a medicament for treating a disease responsive to modulation of the gabaa receptor complex

摘要

This invention relates to novel benzimidazole derivatives of formula (I), pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders which are responsive to modulation of the GABA A receptor complex, and in particular for combating anxiety and related diseases.